CCI
TTOO

Columbus Circle Investors’s T2 Biosystems, Inc TTOO Stock Holding History

Columbus Circle Investors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17
Closed -$1.4M – 316
2015
Q2 		$1.4M Buy
17
+7
+70% +$607K 0.01% 248
2015
Q1 		$804K Hold
10
– – 0.01% 267
2014
Q4 		$997K Buy
+10
New +$824K 0.01% 264

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Columbus Circle Investors's TTOO Position: Q3 2015 in Review

Columbus Circle Investors sold out of T2 Biosystems, Inc (TTOO) in Q3 2015, closing a stake of 17 shares — an estimated $1.4M sold.

Columbus Circle Investors first reported a position in TTOO in Q4 2014 and held it in 3 quarters. The position peaked at $1.4M in Q2 2015. 41 funds tracked by Wall St. Rank hold TTOO as of Q3 2015.

  • Columbus Circle Investors reported no remaining T2 Biosystems, Inc position as of Q3 2015 after selling out during the quarter.
  • Columbus Circle Investors sold 17 T2 Biosystems, Inc shares in Q3 2015, an estimated $1.4M.
  • Columbus Circle Investors first reported a position in T2 Biosystems, Inc in Q4 2014 and held it in 3 quarters.
  • Columbus Circle Investors's T2 Biosystems, Inc position peaked at $1.4M in Q2 2015.
  • 41 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2015.

Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.